Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Publication date
2017-08-22
Authors
Schwab, Claire
Nebral, Karin
Chilton, Lucy
Leschi, Cristina
Waanders, Esme
Boer, Judith M
Žaliová, Markéta
Sutton, Rosemary
Öfverholm, Ingegerd Ivanov
Ohki, Kentaro
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
Keywords
Taverne, Journal Article
Citation
Schwab, C, Nebral, K, Chilton, L, Leschi, C, Waanders, E, Boer, J M, Žaliová, M, Sutton, R, Öfverholm, I I, Ohki, K, Yamashita, Y, Groeneveld-Krentz, S, Froňková, E, Bakkus, M, Tchinda, J, Barbosa, T D C, Fazio, G, Mlynarski, W, Pastorczak, A, Cazzaniga, G, Pombo-de-Oliveira, M S, Trka, J, Kirschner-Schwabe, R, Imamura, T, Barbany, G, Stanulla, M, Attarbaschi, A, Panzer-Grümayer, R, Kuiper, R P, den Boer, M L, Cavé, H, Moorman, A V, Harrison, C J & Strehl, S 2017, 'Intragenic amplification of PAX5 : a novel subgroup in B-cell precursor acute lymphoblastic leukemia?', Blood Advances, vol. 1, no. 19, pp. 1473-1477. https://doi.org/10.1182/bloodadvances.2017006734